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0 The Journal of Thoracic and Cardiovbjective: The aim of the study was to assess the long-term results of a selective
olicy toward pulmonary valve replacement in adult patients with repaired tetralogy
f Fallot and severe pulmonary regurgitation.
ethods: Sixty-seven patients with tetralogy of Fallot were followed up from 15 
years until 27  3 years after surgery.
esults: Twenty-two patients had mild-to-moderate pulmonary regurgitation. No sig-
ificant changes occurred in the follow-up period. Of 45 patients with severe pulmonary
egurgitation and severe right ventricular dilatation, 28 (62%) remained free of symp-
oms and did not undergo pulmonary valve replacement. No changes in right ventricular
ize or exercise capacity were found. In 3 (11%) of 28 patients, QRS duration increased
o more than 180 ms. Seventeen patients had symptoms and underwent pulmonary valve
eplacement: 9 (54%) of 17 patients improved clinically and echocardiographically, and
RS duration shortened postoperatively. Right ventricular dimensions did not regress
espite pulmonary valve replacement in 8 patients.
onclusion: Refraining from pulmonary valve replacement in asymptomatic pa-
ients led to no measurable deterioration in 25 (89%) of 28 patients. Referring
ymptomatic patients for pulmonary valve replacement led to an improvement in
(53%) of 17 patients. In 11 (24%) of 45, a selective approach led to questionable
r unsatisfactory results.
urgical correction of tetralogy of Fallot consists of closure of the ventricular
septal defect and relief of the right ventricular (RV) outflow tract obstruction.
A longitudinal incision from the RV outflow tract across the pulmonary
nnulus into the main pulmonary artery, closed with a transannular patch, was used
iberally in the 1970s and 1980s, because the most important factor associated with
oor survival and ventricular arrhythmias was identified as elevated RV pressure
ersisting after surgery.1-3 The unavoidable consequence of this approach is 
onary regurgitation (PR). PR, even if it is severe, is tolerated remarkably well in
hildhood, but in adolescence and adulthood RV dysfunction develops in some
atients.4,5 Presenting symptoms are signs of venous congestion, deterioration
xercise capacity,6 or arrhythmias, both ventricular7-9 and supraventricular.10,11
ulmonary valve replacement (PVR) for symptomatic patients has been the treat-
ent of choice for years.12-16 In 2000, Therrien and associates17 reported that RV
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Dunction sometimes did not recover after valve replacement,
specially if RV ejection fraction was substantially de-
reased. Because decline in RV ejection fraction, and the
oinciding increase of RV dimensions, is thought to be a
radual process, an intervention earlier in the process was
dvocated.18 In recent years, many have reported low -
ical risks and good short-term results of this policy,19-27
ut no long-term results are yet known. When these results
ecome available, they should be compared with long-term
ollow-up data of the alternative, more selective approach to
elp to determine the optimal timing of PVR.28 This study
resents the outcome of a selective approach in a single-
nstitution, longitudinal, ultra-long-term follow-up study of
cohort of patients with tetralogy of Fallot with varying
egrees of PR and RV dilatation, with emphasis on how
atients fared with severe PR and severe RV dilatation who
ere not operated on.
atients and Methods
total of 77 patients with tetralogy of Fallot, who underwent
ntracardiac surgical repair in our institution between 1968 and
980 at a mean age of 4.7  3.4 years, participated in a follow-up
tudy in 1990, 15  3 years after surgery.10 Since then, all wer
ollowed up at regular intervals at our institutional outpatient
linic. In 2001, they were invited to participate in a second
ollow-up study. Those who responded positively underwent an
xtensive cardiologic and psychologic examination in 2001 and
002. The results of the psychologic study were presented sepa-
ately.29 The study was approved by the local ethical review b
efinition of Subgroups of the Study Population
atients who participated in the second follow-up study were
ivided in 3 groups. Group 1 consisted of patients with mild-to-
oderate PR on the basis of the 1990 echocardiogram. Group 2
omprised patients with severe PR in 1990 who did not undergo
VR. Group 3 consisted of patients with severe PR in 1990 who
nderwent PVR before 2002.
ypes of Measurements
n 2002, all participants underwent the same set of investigations as in
990: medical history, physical examination, 12-lead electrocardio-
ram (ECG), 24-hour ambulatory ECG, echocardiographic examina-
ion, and a bicycle exercise test. In the group with PVR, the indication
or PVR was retrieved. All patients underwent an extensive psycho-
ogic examination, which is reported separately.29
Echocardiographic measurements and definitions. PR and
Abbreviations and Acronyms
ECG electrocardiogram
PR  pulmonary regurgitation
PVR  pulmonary valve replacement
RV  right ventricular
TR  tricuspid regurgitationricuspid regurgitation (TR) were assessed by color Doppler and 5
The Journal of Thoracere classified as absent to light, moderate, or severe. Maxi-
al flow velocity over the pulmonary valve was measured with
ontinuous-wave Doppler. RV dimensions at the level of the RV
utlet were measured by M-mode in the standard parasternal
ong-axis view. RV dimensions at the inlet level were measured in
he apical 4-chamber view just above the tips of the tricuspid
alve, from the interventricular septum to the lateral wall.30 Two
ersons measured, independently from each other, all echocardio-
raphic parameters from both the 1990 and the 2002 study. Pa-
ients who were in sinus rhythm in 1990 and who had ventricular
acing in 2002 were excluded from comparative measurements of
V dimensions.
ECG measurements. The maximum width of the QRS com-
lex was measured in the lead with the longest QRS duration,
sually V1. Patients with a ventricular pacemaker rhythm were
xcluded from the QRS analyses.
Exercise test. Maximal exercise capacity was assessed with bi-
ycle ergometry with stepwise increments of 20 W/min until exhaus-
ion. Tests were assumed to be maximal if the impression was that the
atient had exercised maximally and if greater than 80% of the
argeted maximal heart rate was reached.31 Test results were exclude
f the maximal heart rate was less than 80%. The results are presented
s relative to the predicted value for age, sex, and body length,
tandardized for the Dutch population (M. L. Simoons,32 Computer
ssisted Interpretation of Exercise ECGs. PhD thesis, Rotterdam, The
etherlands, 1976). Patients who were in sinus rhythm in 1990 and
ho had ventricular pacing in 2002 were excluded from comparative
easurements of exercise capacity.
efinitions of Outcomes
he outcome was called satisfactory if the aims of the treatment
ere met: measurable improvement (in terms of ECG, exercise
est, and echocardiographic measurements) in case of PVR and no
igns of deterioration (in terms of ECG, exercise test, and echo-
ardiographic measurements) in the group of patients who were
reated conservatively. The outcome was defined as unsatisfactory
f the treatment aims were not met: no improvement after PVR or
eterioration in the group of patients with conservative treatment.
ignificant increase of echocardiographic measurements, QRS du-
ation greater than 180 ms, or decreased exercise capacity relative
o the test in 1990 were graded as unsatisfactory outcomes.
tatistical Analysis
ime-related data are presented as mean values with standard
eviation. A Fisher exact test was used for comparison of dichot-
mized variables. A Student t test was used for comparison of 2
ets of continuous variables.
esults: Study Participation and Subgroup Analysis
ince 1990, all patients were checked regularly at our out-
atient clinic, with intervals between visits ranging from 1
o 3 years. Visits included history, physical examination,
2-lead ECG, and occasionally echocardiography. Sixty-
even patients, 87% of the patients who had participated in
he 1990 study, had an extensive cardiologic evaluation in
002, 26  3 years after surgery. The mean age was 30 
years. Group 1, with mild-to-moderate PR, comprised 22
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Datients. Group 2, severe PR in 1990 and not having under-
one PVR, consisted of 28 patients. Group 3 comprised 17
atients with PVR 18.6  5.4 years after surgical correc-
ion. In Table 1 the most important differences between
ubgroups are shown. Table 2 summarizes the change
ime of echocardiographic parameters, QRS duration, and
esults of the exercise test.
Mild-to-moderate PR (n  22). None of the 22 patients
ad symptoms: no arrhythmia and no decrease in exercise
apacity. None of these patients used medication and none
ad signs of venous congestion.
ECHOCARDIOGRAPHIC RESULTS. The degree of regurgitation
nd the RV dimensions, both at the inflow and at the outflow
ract level, had not changed significantly in 12 years. None
f the patients in this group had more than mild TR.
ECG. All patients were in sinus rhythm. None of the pa-
ients had a QRS duration of 180 ms or more.
EXERCISE TEST. In 22 of 22 patients (100%), a conserva-
ive treatment had led to a satisfactory outcome (Tabl
Severe PR; no PVR (n  28). Twenty-six (93%) pa-
ients reported no symptoms between 1990 and 2002. Two
atients had had one period of atrial fibrillation, for which
irect-current cardioversion was performed; they remained
symptomatic afterward, without medication. In 2002, no-
ody used cardiac medication. None of these patients had
igns of venous congestion.
ECHOCARDIOGRAPHIC ANALYSIS. The relevant echocardio-
raphic parameters of this group and the changes over time
re presented in Table 2. One patient had moderate T
7 patients the TR was not more than mild.
ECG. All 28 patients were in sinus rhythm in 1990 and in
002. In Table 2, the change in QRS duration betwe
990 and 2002 is shown. There was a statistically significant
ncrease in QRS duration in the whole group of patients; the
umber of patients with a QRS duration of more than 180





No PVR With PVR
o. of patients 22 28 17
urgical data
Age at operation (y) 5.3 3.3 3.5 2.5 4.2 3.4
Prior palliation: n (%) 4 (18%) 8 (30%) 9 (50%)
Transannular patch: n (%) 2 (9%) 20 (74%) 14 (78%)
Cold cardioplegia: n (%) 7 (32%) 13 (48%) 9 (50%)
ollow-up
Age in 2002 (y) 30.9 5.7 27.7 4.7 27.6 5.8
Years after surgery 25.4 2.8 23.9 2.6 23.3 2.7
Years after PVR 6.4 4.4
R, Pulmonary regurgitation; PVR, pulmonary valve replacement.s increased from 2 to 3. w
2 The Journal of Thoracic and Cardiovascular Surgery ● Janua.
n
n EXERCISE TEST. In Table 2 results of the exercise tes
990 and 2002 are shown. The exercise capacity in this
roup is significantly worse than that in the group with
ild-to-moderate PR (P .01). Neither in 1990 nor in 2002
ABLE 2. Changes in echocardiographic parameters, ECG,





ild/moderate PR (n  22)
chocardiography (n  22)
RVOT diastole (mm) 27 5 26  8 .7
RVOT systole (mm) 23 6 22  6 .6
RV inlet diastole (mm) 49 7 50  6 .6
RV systole (mm) 37 6 38  5 .5
PA Vmax (m/s) 1.9 0.8 2.3 0.9 .01
CG (n  22)
Mean QRS duration (ms) 106 27 117 25 .001
QRS  180 ms (No of
patients)
0 0
xercise test (n  22)
% of predicted 91 13 92 16 .6
evere PR; no PVR (n  28)
chocardiography (n  28)
RVOT diastole (mm) 39 8 39  8 .95
RVOT systole (mm) 32 8 33  8 .69
RV inlet diastole (mm) 52 9 54  10 .18
RV inlet systole (mm) 41 8 43  7 .46
PA Vmax (m/s) 1.8 0.8 1.9 1.0 .16
CG (n  28)
Mean QRS duration (ms) 123 27 145 29 .0001
QRS  180 ms (No. of
patients)
2 3
xercise test (n 28)
% of predicted 78.0 19 82  14 .32
VR (n  17)
chocardiography (n  13)
RVOT diastole (mm) 40 8 32  7 .001
RVOT systole (mm) 35 7 27  7 .001
RV inlet diastole (mm) 53 8 52  8 .61
RV inlet systole (mm) 42 8 42  8 .90
PA Vmax (m/s) 2.1 0.9 2.4 0.8 .20
CG (n  13)
Mean QRS duration (ms) 125 25 150 31 .001
QRS  180 ms (No. of
patients)
1 4
xercise test (n  13)
% of predicted 71 19 76 15 .29
CG, Electrocardiographic; N, number of patients in group or participating
n test; PR, pulmonary regurgitation; PVR, pulmonary valve replacement;
V, right ventricle; RVOT, right ventricular outflow tract; PA, pulmonary
rtery; Vmax, maximal flow velocity measured with Doppler; % of pre-
icted, relative to the predicted value based on sex, age, and body length
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Dween the group with severe PR who did receive a ho-
ograft and the group that did not.
The 3 patients with a QRS duration of more than 180 ms
ere graded as having an unsatisfactory outcome; the
utcome in 25 (89%) of 28 patients was regarded as
atisfactory.
PVR (n  17). Of the 45 patients with severe PR and
evere RV dilatation in 1990, 17 (38%) had symptoms that
ad prompted PVR. Nine patients had a worsened exercise
apacity, without signs of clinical or echocardiographic
eterioration. Of these, 2 patients had atrial fibrillation.
hree patients had the combination of a decrease in exercise
apacity and an increase in central venous pressure. Three
ther patients had elevated central venous pressure without
ymptoms. Two patients had recurrent episodes of ventric-
lar tachycardia.
In terms of baseline conditions (age at operation, use of
ransannular patch, use of cold cardioplegia, and duration of
ollow-up) and data from the 1990 study, there were no
ignificant differences between patients who had symptoms
nd patients who did not.
The mean interval between primary surgical correction
nd PVR was 18.6  5.4 years. The mean follow-up after
VR was 6.4  4.4 years. Four patients received a pace-
aker: 2 patients with advanced atrioventricular block and
patients with atrial fibrillation and an unstable ventricular
hythm. One of the 2 patients with ventricular tachycardias
eceived an implantable cardioverter–defibrillator. None of
hese patients died and the postoperative course was un-
ventful in all. The venous congestion disappeared in all
atients. Seven of 9 patients who were operated on because
f progressively diminished exercise capacity reported an
mproved exercise capacity after valve replacement. De-
reased exercise capacity persisted after surgery in 2 pa-
ients; both had an RV inlet diameter measured with echo-
ardiography that had become larger postoperatively.
ECHOCARDIOGRAPHIC RESULTS. In Table 2 the changes 
V dimensions between 1990 and 2002 are shown. Four
atients with a pacemaker were excluded from comparative
easurements. In all patients the RVOT dimensions had
ecreased substantially. The mean diameter of the RV inlet
iameter of the patients as a group did not change signifi-
antly, but in 9 of 13 the RV inlet diameter diminished
ignificantly compared with preoperatively, with a mean
ecrease of 14%  4%. In 2 patients the RV inlet diameter
id not change; 2 other patients showed an increase of
V inlet diameter, with an increment of 14% and 39%,
espectively.
PR was absent or mild in 16 patients and severe in 1
atient.
In terms of baseline variables—age at operation, prior
alliation, use of transannular patch, and cold cardioplegia—and
he conditions measured after 15 years of follow-up, the t
The Journal of Thoracatients who did not show a decrease in size of the RV at the
nlet level were not significantly different from the group of
atients who were operated on and improved in terms of
oth inlet and RV outflow tract diameter.
ECG. In 2002, 13 patients had sinus rhythm and 4 had a
acemaker rhythm. Of these, 2 had atrial fibrillation. The
RS duration had increased substantially before PVR, from
32  28 ms in 1990 to 166  30 ms on the last ECG
efore valve replacement (P  .000). In 2002, 4 patients
ith pacemaker rhythm were excluded from comparison.
rom the remaining 13 patients, 10 (77%) showed a signif-
cantly shorter QRS duration than just before valve replace-
ent, with a mean value of 144  26 ms (P  .01). Three
atients had a persisting broad QRS complex with duration
f 180 ms or more, but no further prolongation.
EXERCISE TEST. The 9 patients with a decrease in diameter
f both RV inlet and RV outflow tract showed an increased
xercise capacity, from 72% 25% in 1990 to 81% 22%
n 2002 (P  .05). The 4 patients with an unchanged or in-
reased RV inlet diameter showed no significant change in
xercise capacity, from 77%  4% in 1990 to 73%  3%
n 2001 (P  .4). The 4 patients with pacemaker rhythm
ere excluded from comparison.
In 9 (53%) patients with a significant reduction of the RV
t both the inlet and outlet levels, who also showed short-
ning of the QRS duration and improvement of the exercise
apacity, the outcome was graded as satisfactory. The 8
ther patients, including the 4 patients with pacemaker
mplantation, were graded as having an unsatisfactory
utcome.
iscussion
or the duration of the follow-up, refraining from PVR has
ed to a satisfactory outcome in all patients with no more
han moderate PR and in 89% of the asymptomatic patients
ith severe PR and severe RV dilatation. In only 11% of the
symptomatic patients with severe PR was the outcome
raded as unsatisfactory on the basis of a QRS duration of
ore than 180 ms. In light of the evidence about the risks of
udden death and ventricular tachycardia in patients with a
RS duration greater than 180 ms8,33-36 and the studies
ncluding ours, that QRS duration can shorten after PV37
he decision not to replace the pulmonary valve is question-
ble for these patients. Has the policy of delaying PVR until
fter the onset of symptoms led to a good outcome? The
ymptoms that prompted PVR disappeared in 15 (88%) of
7 patients. In all surgically treated patients there was a
ignificant reduction in dimensions of the RVOT, but this
annot be attributed to abolishment of PR alone. It also
eflects the effects of surgical remodeling of the RV outflow
ract: excision of the often aneurysmatically dilated transan-
ular patch38 and reduction of the RV outflow tract to a
hat enables anastomosis with the homograft. Dimension at
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Dhe level of the RV inlet, without being touched by the
urgeon and without surgical scars, probably is a better
easure of improvement of the RV after PVR. This was
iminished in 9 of 17 patients. These 9 patients also showed
significant reduction of QRS duration and an improvement
f exercise capacity; they were graded as having a satisfac-
ory outcome. In 4 patients, the RV inlet diameter did not
iminish and in 4 other patients the ECG and RV echocar-
iographic measurements before and after PVR were not
omparable because of a pacemaker insertion at the time of
VR. We conclude that the outcome was unsatisfactory in
hese 8 (47%) of 17 surgically treated patients. This seems
o confirm the report of Therrien and associates17 that the
ondition of some patients does not improve after PVR.
ossibly, these patients might have benefited from earlier PVR.
Summarizing, we can conclude that the selective policy
oward PVR has led to an unsatisfactory or uncertain result
n 11 (24%) of 45 patients but to a satisfactory outcome in
4 (76%) of 45 patients.
Inasmuch as the patients whose condition did not im-
rove after PVR could not be identified beforehand with the
iagnostic tools that are currently available in clinical prac-
ice, early PVR for all patients with severe PR and RV
ilatation can be considered, hoping that early PVR will
educe the percentage of patients who will not improve after
he procedure. If the presence of severe PR and severe RV
ilatation would have been indications to replace the pul-
onary valve in our study population in 1990, approxi-
ately half of these patients (20-25 patients) would proba-
ly have had re-replacement by now, because of the mean
urvival of homografts or porcine valves used for this indi-
ation.39 That would have meant 45 PVRs in 45 patien
990 and probably a total of 60 to 70 PVRs by now, instead
f the 17 valve replacements in this study. The treatment
ptions seem to be either overtreatment of a large propor-
ion of the patients (ie, early valve replacement in all
atients) or undertreatment in a much smaller, but still
onsiderable proportion of patients by referring only
ymptomatic patients.
Supported by good ultra–long-term survival of patients
ith tetralogy of Fallot after surgical repair reported by
ollow-up studies done before the era in which early PVR
ecame fashionable,39,40 we think that for patients like th
escribed in this study, a selective approach should still be
onsidered a serious treatment option as an alternative for
arly PVR. The most important drawback of this study, al-
hough describing one of the longest durations of follow-up of
consecutive series of patients reported so far, is that the
uration of follow-up is still too short to assess the effect of
ong-standing (lifelong) volume overload on the RV. This
emains to be established, and only when these data become
vailable will we learn more about the optimal timing of PVR. s
4 The Journal of Thoracic and Cardiovascular Surgery ● JanuaThis study represents our clinical practice: if there are
igns that might be attributed to worsening of RV function—
ymptoms, development of venous congestion, significant
ncrease of QRS duration, or increase of RV size measured
ith echocardiography or magnetic resonance imaging—we
efer the patient for PVR. History taking and a good phys-
cal examination, maybe undervalued in the high-technology
nvironment that cardiology is nowadays, are still very
mportant. If the patient has severe PR and a substantially
ilated RV, but is entirely stable in all respects, we discuss
he treatment options with the patient, do not advise PVR,
ut advise regular follow-up with echocardiography and/or
agnetic resonance imaging every year. If, during follow-
p, deterioration occurs, we advise PVR. New treatment
ptions, such as percutaneous PVR, will probably become
vailable in the coming years for our patients with very
ide RVOTs. Whether these will change not only the exe-
ution of PVR but also its indication remains to be
stablished.
Mild-to-moderate PR in combination with mild-to-moderate
V dilatation is tolerated extremely well long term after sur-
ical correction of tetralogy of Fallot in childhood. There is no
endency toward increase of degree of PR, and RV size does
ot increase in time. The exercise capacity is nearly normal, the
RS complex is still narrow, despite a statistically significant
ncrease in duration in 12 years, and no arrhythmias are re-
orted or detected. On the basis of these data, there seems to be
o indication to consider PVR for these patients.
imitations of the Study
part from the duration of follow-up which is still not long
nough to give a lifelong perspective for these patients, the
mall number of patients and the fact that RV dimensions
ere not assessed by magnetic resonance imaging are the
ost important limitations of the study. Magnetic resonance
maging, the tool for assessment of global RV function
owadays, was not available in 1990, and we chose to use
chocardiography for longitudinal follow-up with every pa-
ient as his or her own control.
onclusions
n this ultra–long-term follow-up study of patients with long-
tanding, severe PR and RV dilatation after surgical repair of
etralogy of Fallot in childhood, the policy of refraining from
VR in asymptomatic patients and doing a PVR only in
ymptomatic patients led to a good outcome in a large majority
f patients. This policy is different from the recently much-
dvocated early PVR. Outcomes like those from this study can
e used as benchmark when the long-term result of early PVR
ecome available in the coming years.
We offer special thanks to Ms Willeke van der Bent, research
ssistant, who was responsible for the database management of the
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